Resource Center

Go back to Resource Center

Effect of the oral PKC b Inhibitor, Ruboxistaurin, on vision loss in patients with diabetic retinopathy: The PKC-DRS2 study results

2006

Journal Article

Authors:
Aiello, L.P.; Vignati, L.; , ; Zhi, X.; Davis, M.D.; Milton, R.C.; Group, G.A. for the

Location:
Aarhus, Denmark

Go back to Resource Center